NCT04816461 - Boosting the Impact of SMC Through Simultaneous Screening and Treatment of Roommates | Biotech Hunter

Enrollment

526

Participants

Timeline

Start Date

July 7, 2021

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions

MalariaMalaria ProphylaxisMass Testing and Treatment

Interventions

DRUG

Amodiaquine Sulfadoxine-Pyrimethamin administration

SMC treatment

DRUG

Dihydroartemisinin-Piperaquine

Roommates treatment if they are positive to malaria

DIAGNOSTIC_TEST

Standard HRP2-RDT

Roommates screening with standard HRP2-RDT

Trial Locations (1)

Institut de Recherche en Sciences de la Santé/ Clinical Research Unit of Nanoro, Nanoro

All Listed Sponsors

lead

Institut de Recherche en Sciences de la Sante, Burkina Faso

OTHER_GOV